Moleculin Biotech Files 8-K with Corporate Updates

Ticker: MBRX · Form: 8-K · Filed: May 5, 2025 · CIK: 1659617

Sentiment: neutral

Topics: corporate-disclosure, filing

Related Tickers: MBRX

TL;DR

Moleculin Biotech (MBRX) filed an 8-K on 5/5/25 detailing corporate info and exhibits.

AI Summary

Moleculin Biotech, Inc. filed an 8-K on May 5, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's principal executive offices located at 5300 Memorial Drive, Suite 950, Houston, TX 77007, and its telephone number is 713-300-5160. The company is incorporated in Delaware and its fiscal year ends on December 31.

Why It Matters

This filing provides essential corporate information and disclosures, which are important for investors to stay informed about the company's operational and financial status.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not contain significant new financial or operational information that would inherently increase risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Moleculin Biotech, Inc.?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on May 5, 2025.

Where are Moleculin Biotech, Inc.'s principal executive offices located?

Moleculin Biotech, Inc.'s principal executive offices are located at 5300 Memorial Drive, Suite 950, Houston, TX 77007.

What is the telephone number for Moleculin Biotech, Inc.?

The telephone number for Moleculin Biotech, Inc. is (713) 300-5160.

In which state is Moleculin Biotech, Inc. incorporated?

Moleculin Biotech, Inc. is incorporated in Delaware.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 5, 2025 regarding Moleculin Biotech, Inc. (MBRX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing